Health needs of the country, the experts at the meeting suggested that the project should approve the Pfizer BNT vaccine for children aged 6 months to 4 years. micrograms of mRNA), the first 2 doses should be administered at least 21 days apart, and the third dose should be administered at least 8 weeks after the second dose. In clinical trials, the most common adverse reactions reported by children aged 6 months to under 2 years who received any dose of the vaccine included agitation, decreased appetite, injection site tenderness, injection site redness, fever and injection site swelling, the FDA said.
The most common adverse reactions in children phone database aged 2 to 4 include injection site pain, fatigue, injection site redness, fever and headache. No cases of myocarditis, pericarditis or death were found in clinical trials. Zhou Zhihao, head of the epidemic monitoring team of the command center, said at a press conference on July 27 that Pfizer's BNT infant vaccine has almost reached the final stage of the contract, and hopes to complete the process as soon as possible so that the vaccine can arrive as soon as possible.